Literature DB >> 26279492

Forkhead box O transcription factors as possible mediators in the development of major depression.

Haitao Wang1, Rémi Quirion2, Peter J Little3, Yufang Cheng4, Zhong-Ping Feng5, Hong-Shuo Sun5, Jiangping Xu6, Wenhua Zheng7.   

Abstract

Forkhead box O (FoxO) transcription factors play important roles in cellular physiology and biology. Recent findings indicate that FoxOs are also involved in the development of major depressive disorder. Alterations in the upstream molecules of FoxOs, such as brain derived neurotrophic factor or protein kinase B, have been linked to depression. Antidepressants, such as imipramine and venlafaxine, modify the FoxOs phosphorylation. Furthermore, FoxOs could be regulated by serotonin and norepinephrine receptor signaling as well as the hypothalamic-pituitary-adrenal axis, all of which are involved in the pathogenesis of depression. FoxOs also regulate neuronal morphology, synaptogenesis and adult hippocampal neurogenesis, which are viewed as candidate mechanisms for the etiology of depression. In this review, we emphasize the possible roles of FoxOs during the development of depression and make some strategic recommendations for future research. We propose that FoxOs and its signaling pathways may constitute potential therapeutic targets in the treatment of depression.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antidepressants; FoxO; Major depression; Neurogenesis; Neuronal atrophy; PI3K/Akt

Mesh:

Substances:

Year:  2015        PMID: 26279492     DOI: 10.1016/j.neuropharm.2015.08.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  Short-term environmental enrichment, and not physical exercise, alleviate cognitive decline and anxiety from middle age onwards without affecting hippocampal gene expression.

Authors:  Gaurav Singhal; Julie Morgan; Magdalene C Jawahar; Frances Corrigan; Emily J Jaehne; Catherine Toben; James Breen; Stephen M Pederson; Anthony J Hannan; Bernhard T Baune
Journal:  Cogn Affect Behav Neurosci       Date:  2019-10       Impact factor: 3.282

2.  Cacna1c in the Prefrontal Cortex Regulates Depression-Related Behaviors via REDD1.

Authors:  Zeeba D Kabir; Anni S Lee; Caitlin E Burgdorf; Delaney K Fischer; Aditi M Rajadhyaksha; Ethan Mok; Bryant Rizzo; Richard C Rice; Kamalpreet Singh; Kristie T Ota; Danielle M Gerhard; Kathryn C Schierberl; Michael J Glass; Ronald S Duman; Anjali M Rajadhyaksha
Journal:  Neuropsychopharmacology       Date:  2016-12-06       Impact factor: 7.853

3.  Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.

Authors:  Bingqing Zeng; Yiwen Li; Bo Niu; Xinyi Wang; Yufang Cheng; Zhongzhen Zhou; Tingting You; Yonggang Liu; Haitao Wang; Jiangping Xu
Journal:  J Mol Neurosci       Date:  2016-07-13       Impact factor: 3.444

Review 4.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  [Effects of ring finger and tryptophan-aspartic acid 2 on dendritic spines and synapse formation in cerebral cortex neurons of mice].

Authors:  T Sun; Y Wang; Z Fang; J Xu; S Ma; J Chang; G Liu; Y Guo; C Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-01-20

Review 6.  Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.

Authors:  Qin Li; Limor Rubin; Marta Silva; Shuai Li; Chao Yang; Philip Lazarovici; Wenhua Zheng
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

7.  Association analysis in over 329,000 individuals identifies 116 independent variants influencing neuroticism.

Authors:  Michelle Luciano; Saskia P Hagenaars; Gail Davies; W David Hill; Toni-Kim Clarke; Masoud Shirali; Sarah E Harris; Riccardo E Marioni; David C Liewald; Chloe Fawns-Ritchie; Mark J Adams; David M Howard; Cathryn M Lewis; Catharine R Gale; Andrew M McIntosh; Ian J Deary
Journal:  Nat Genet       Date:  2017-12-18       Impact factor: 38.330

Review 8.  Elucidating the Possible Role of FoxO in Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Vineet Mehta; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-06-01       Impact factor: 3.996

Review 9.  The involvement of DARPP-32 in the pathophysiology of schizophrenia.

Authors:  Haitao Wang; Mohd Farhan; Jiangping Xu; Philip Lazarovici; Wenhua Zheng
Journal:  Oncotarget       Date:  2017-04-21

10.  Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice: Involvement of p38 and JNK Signaling Pathways.

Authors:  Hui Yu; Zhengqiang Zou; Xiaolin Zhang; Wanli Peng; Chen Chen; Yicheng Ye; Jiangping Xu; Haitao Wang
Journal:  Int J Mol Sci       Date:  2018-02-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.